Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 1,721,300 | 1,471,800 | 1,346,200 | 1,387,100 | 1,492,500 |
| Cost of Goods | 1,303,100 | 1,111,900 | 1,020,400 | 1,069,000 | 1,078,700 |
| Gross Profit | 418,200 | 359,900 | 325,800 | 318,100 | 413,800 |
| Operating Expenses | 250,600 | 216,700 | 206,800 | 204,300 | 237,900 |
| Operating Income | 167,700 | 144,100 | 119,400 | 113,800 | 176,600 |
| Interest Expense | 17,400 | 16,200 | 16,500 | 19,600 | 25,100 |
| Other Income | 22,100 | 1,500 | 7,300 | 6,900 | 119,600 |
| Pre-tax Income | 172,400 | 129,400 | 110,200 | 101,100 | 271,100 |
| Income Tax | 41,400 | 36,600 | 30,900 | 34,900 | 93,500 |
| Net Income Continuous | 131,000 | 92,800 | 79,300 | 66,200 | 177,600 |
| Net Income Extraordinary | N/A | N/A | N/A | 4,900 | N/A |
| Net Income | $131,000 | $79,200 | $79,300 | $71,100 | $177,600 |
| EPS Basic Total Ops | 1.53 | 1.02 | 1.01 | 0.89 | 2.17 |
| EPS Basic Continuous Ops | 1.53 | 1.19 | 1.01 | 0.83 | 2.17 |
| EPS Diluted Total Ops | 1.48 | 0.99 | 0.98 | 0.86 | 2.08 |
| EPS Diluted Continuous Ops | 1.48 | 1.16 | 0.98 | 0.80 | 2.08 |
| EBITDA(a) | $261,500 | $237,700 | $203,100 | $204,100 | $273,200 |